\u201cAlong with the ELT, we are very pleased to welcome Gwenan to Ipsen. She will be critical to the implementation of our new strategy,\u00a0<\/em>Focus. Together. For patients & society. Her background in communications and public affairs will help reinforce Ipsen\u2019s position as partner and employer of choice and will contribute to developing the share-of-voice of our innovative medicines. We look forward to working closely with her,\u201d<\/em>\u00a0said David Loew, CEO, Ipsen.
\u201cI\u2019m excited to join Ipsen at this key moment<\/em>,\u201d said Gwenan White.\u00a0\u201cI look forward to further building Ipsen\u2019s relationships and engagement with institutions and stakeholders worldwide, ensuring the strategic alignment of its communications and boosting the visibility of its brands.\u201d<\/em>
Prior to joining Ipsen, Gwenan was the Global Head of Pharma Communications and Patient Advocacy at Novartis Pharmaceuticals. Over the course of her career, she has held a variety of roles in public affairs, corporate, science and product communications, patient advocacy and marketing at AbbVie, GSK and Schering Plough.
Gwenan is a graduate of the University of Liverpool in BSc (Hons) Biochemistry in 1990.
She will be based in Boulogne \u2013 France.<\/p>\n
<\/p>\n
\n Attachment<\/strong>\n<\/p>\n
<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"template":"","categories":[1763,149],"tags":[],"class_list":["post-36207","press_release","type-press_release","status-publish","hentry","category-corporate-pressrelease","category-pressrelease","entry"],"acf":[],"yoast_head":"\n